Chronic Lymphocytic Leukemia Requires BCL2 to Sequester Prodeath BIM, Explaining Sensitivity to BCL2 Antagonist ABT-737

Journal of Clinical Investigation - United States
doi 10.1172/jci28281
Full Text
Abstract

Available in full text

Categories
Medicine
Date
Authors
Publisher

American Society for Clinical Investigation

Related search

Cap-Translation Inhibitor, 4egi-1, Restores Sensitivity to ABT-737 Apoptosis Through Cap-Dependent and -Independent Mechanisms in Chronic Lymphocytic Leukemia

Clinical Cancer Research
Cancer ResearchOncology
2013English

BCL2-associated X Protein (BAX); BCL2-antagonist/killer 1 (BAK1)

Science-Business eXchange
2010English

BCL2 (B-Cell Leukemia/Lymphoma 2)

Atlas of Genetics and Cytogenetics in Oncology and Haematology
Cancer ResearchOncologyGeneticsHematology
2018English

Genetic Susceptibility to Chronic Lymphocytic Leukemia

Leukemia
Cancer ResearchOncologyAnesthesiologyPain MedicineHematology
2002English

Glycolysis Inhibition Targets McL-1 to Restore Sensitivity of Lymphoma Cells to ABT-737-induced Apoptosis

Leukemia
Cancer ResearchOncologyAnesthesiologyPain MedicineHematology
2011English

Chronic Lymphocytic Leukemia

Current Opinion in Hematology
Hematology
1998English

Chronic Lymphocytic Leukemia

Orvosi Hetilap
Medicine
2008English

Chronic Lymphocytic Leukemia

ASH Image Bank
2003English

Chronic Lymphocytic Leukemia

Molecular and Translational Medicine
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy